|Day Low/High||13.94 / 15.19|
|52 Wk Low/High||4.75 / 15.30|
In the interest of due diligence, we went and took a close look at the ground floor of the newest investment craze.
What matters here is the ability to innovate, market, and sell.
Establishing who the stragglers are and what impact they might have in the future is the key at this point.
I'd be most interested in buying this name after a cap raise which I expect in the first quarter of 2019.
The buy-in from other companies into the space has been far larger.
After Altria's investment in Cronos Group, which cannabis company will be the next target?
The tobacco giant is being threatened on two fronts: e-cigarettes in the form of Juul and cannabis.
Shorts aren't shying away from the cannabis industry even after a series of squeezes.
Consumer Discretionary stocks were the hottest on Wednesday, though all eleven sectors easily finished in the green.
An early look at the market shows supply is finding it tough to keep up with demand.
A bunch of pot stocks are in play on Tuesday -- for a reason.
In the "dumbass trade department" - though yielding a profit, my recent sales of , , and were truly stupid.
I have sold my three pot trading rental longs right after the opening - , and - for a profit. Of the trading rentals I established recently, only Twitter and Northrop remain in my portfolio - and for the time being I plan to hold on to them. I am ...
* Rentals are not long term leases! The S&P is +34 points, Nasdaq +95 handles and the Dow Jones Industrial Average is now +360. As posted, I just sold out my Index longs. I am now selling out my Alphabet , Amazon and Boeing trading rentals for so...
MSFT is never going to be a big time growth stock again.
On Wednesday, Canada becomes the first major economy to legalize the recreational use of cannabis.
Covered calls may be the best bet -- or wait for a dip.
Not every cannabis stock was strong on Wednesday. One significant Canadian name sure was though.
The underlying action, particularly the weakness in the technology sector, is reason for concern.
Facebook still needs to prove to the market that it can regain operational footing.
Despite Monday's pop, FB stock has a bunch of issues working against it.
Seasonality hasn't mattered in a number or years so why should light volume new highs be an issue?
What is most notable about this market is that there is no negative narrative able to gain traction.
The Nasdaq-listed provider of medical marijuana will compete with other firms as Canada opens itself to general adult use of marijuana this fall.